Renaissance Technologies LLC reduced its stake in TRxADE HEALTH, Inc. (NASDAQ:MEDS – Free Report) by 65.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,700 shares of the company’s stock after selling 21,682 shares during the quarter. Renaissance Technologies LLC owned approximately 0.83% of TRxADE HEALTH worth $131,000 at the end of the most recent reporting period.
Separately, Virtu Financial LLC acquired a new stake in shares of TRxADE HEALTH during the 1st quarter worth approximately $109,000. 5.68% of the stock is owned by hedge funds and other institutional investors.
TRxADE HEALTH Price Performance
Shares of TRxADE HEALTH stock opened at $7.59 on Monday. The company’s fifty day moving average price is $7.31 and its two-hundred day moving average price is $8.70. TRxADE HEALTH, Inc. has a 52-week low of $3.69 and a 52-week high of $44.56.
TRxADE HEALTH Company Profile
TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.
Further Reading
- Five stocks we like better than TRxADE HEALTH
- Breakout Stocks: What They Are and How to Identify Them
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- The 3 Best Fintech Stocks to Buy Now
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for TRxADE HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TRxADE HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.